Survival Rates After HCV-related Liver Transplant Rise on Administration of DAAs

"/
Investigators from Catalonia reported in the Journal of Hepatology that survival rate among hepatitis C virus (HCV) positive patients undertaking liver transplant have significantly risen after the administration of direct-acting antivirals (DAAs). DAAs also lead to a fall in the number of people with HCV requiring a liver transplant.
The authors note, “Although not unexpected considering the efficacy of these drugs, our findings suggest for the first time that the main problem of LT [liver transplant] programmes around the world, hepatitis C recurrence, will no longer impact on patient and graft survival. These results support and recognize those public health programmes that have permitted widespread access to DAA to hepatitis C patients with advanced liver disease, and encourage the policies aimed to expand the access to all patients with HCV infection.”
DAAs have transformed the management and prognosis of chronic HCV infection in patients. The therapy can attain cure rates in more than 90% of cases, including people with decompensated cirrhosis, if well endured.
Since HCV is the leading cause of referral for liver transplant in western countries, investigators in Catalonia wanted to observe the impact of DAAs on the composition of waiting lists for liver transplants and on short-term post-transplant survival.
Hence, data were analyzed from all patients admitted to the liver transplant waiting list in Catalonia between 2008 and 2016. The time period was divided into two stages: 2008 to 2013 when HCV was treated with interferons; and 2014 to 2016, when DAAs were used. The authors noted variations in reasons for liver transplants and post-transplant survival and analyzed the results.
By Ddu
The post Survival Rates After HCV-related Liver Transplant Rise on Administration of DAAs appeared first on Drugdu.com
from Drugdu  https://goo.gl/QgQoHk

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文